These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 15950641
1. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R. Fertil Steril; 2005 Jun; 83(6):1717-23. PubMed ID: 15950641 [Abstract] [Full Text] [Related]
8. [Exploration of the classification of polycystic ovarian syndrome]. Lin JF, Li X, Zhu MW. Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924 [Abstract] [Full Text] [Related]
9. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z. Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [Abstract] [Full Text] [Related]
11. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women. Anaforoglu I, Algun E, Incecayir O, Ersoy K. Metab Syndr Relat Disord; 2011 Oct; 9(5):375-80. PubMed ID: 21657888 [Abstract] [Full Text] [Related]
12. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome. Fulghesu AM, Angioni S, Portoghese E, Milano F, Batetta B, Paoletti AM, Melis GB. Fertil Steril; 2006 Aug; 86(2):398-404. PubMed ID: 16769061 [Abstract] [Full Text] [Related]
13. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome. Toscani M, Migliavacca R, Sisson de Castro JA, Spritzer PM. Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263 [Abstract] [Full Text] [Related]
14. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Ozdemir S, Ozdemir M, Görkemli H, Kiyici A, Bodur S. Acta Obstet Gynecol Scand; 2010 Jul; 89(2):199-204. PubMed ID: 19900078 [Abstract] [Full Text] [Related]
19. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A. Fertil Steril; 2007 Nov; 88(5):1389-95. PubMed ID: 17462641 [Abstract] [Full Text] [Related]